EpiPen® information for healthcare professionals


Did you know Viatris offers a free expiry alert service for patients?

Illustration of mobile phone

Patients can sign up for our expiry alert service and receive free reminders by text or email when their EpiPen is about to expire. Patients can sign up HERE

SIGN UP HERE

Treating
anaphylaxis

Adrenaline is the first-line treatment for severe allergic reactions to food, insect stings, medication, latex, exercise and other allergens and classified as an essential medication for the treatment of anaphylaxis.1

Read more

EpiPen®
explained

EpiPen® is an adrenaline auto-injector (AAI) used for self administration of adrenaline for the emergency treatment of severe allergic reactions (anaphylaxis).2,3

Read more

Patient
support

Viatris is committed to supporting patients with anaphylaxis and has produced a number of resources to help.

Read more

Advice

Advice about the management of anaphylaxis, which recommends adrenaline as immediate first-line treatment.

READ MORE

EpiPen® Trainer Pen

How to use the EpiPen® Trainer and order a training kit.

READ MORE

Abbreviated Prescribing Information (AbPI)

Click here to read the AbPI.

READ MORE

References

1. Cardona, Victoria et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organization Journal, Volume 13, Issue 10, 100472.

2. EpiPen® (adrenaline) 300 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics. Available at: www.medicines.ie. Last accessed: 24th October 2025.

3. EpiPen Junior® (adrenaline) 150 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics. Available at: www.medicines.ie. Last accessed: 24th October 2025.


The website you are trying to access is designed for healthcare professionals, the content is not designed for the general public.


Are you a healthcare professional registered in Ireland?

YES
NO

EpiPen® (adrenaline) and EpiPen® Junior (adrenaline) Auto-Injectors are indicated in the emergency treatment of severe allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs and other allergens, as well as idiopathic or exercise induced anaphylaxis.

Product subject to medical prescription which may be renewed (B)

This site is designed for healthcare professionals registered in Ireland, if you are not a healthcare professional registered in Ireland, please
click here to visit our patient website.

For full prescribing information please see:

EpiPen® (adrenaline) 300 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics

EpiPen® Junior (adrenaline) 150 micrograms solution for injection in pre-filled pen, Summary of Product Characteristics

For abbreviated prescribing information (AbPI) please see:

EpiPen 300 micrograms solution for injection in pre-filled pen Abbreviated Prescribing Information (AbPI)

EpiPen Junior 150 micrograms solution for injection in pre-filled pen Abbreviated Prescribing Information (AbPI)

This website is owned and managed by Viatris.

©2025 Viatris. All rights reserved.

Viatris, Newenham Court, Northern Cross, Malahide Road, Dublin 17, Ireland.

Job Code: IE-EPI-2025-00014
Date of preparation: October 2025

Reporting of adverse reactions:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.


Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system HPRA Pharmacovigilance, Website: www.hpra.ie


Adverse reactions/events should also be reported to the marketing authorisation holder at email address: pv.ireland@viatris.com or phone 0044 (0) 800 1218267.